MucoLife Therapeutics AB
Developing novel mucus modulators to treat COPD and Cystic Fibrosis.
Översikt
- 1–4
- Anställda
- ≤1t SEK
- Omsättning
- 2023
- Grundat
Nyckelbeslutsfattare
Kicki Johansson
Chief Development Officer
Jesper Magnusson
Board Member
Gunnar C. Hansson
Co-founder and Chief Scientific Officer
Jim Shaffer
Chief Business Officer
+6 fler kontakter i Funnelfeedr
Beskrivning
MucoLife Therapeutics is a pioneering biotechnology firm dedicated to transforming the treatment landscape for chronic lung diseases. The company specifically targets pulmonary mucus obstruction, a debilitating symptom affecting patients with conditions like Chronic Obstructive Pulmonary Disease (CO...